Newly Approved Drug Therapies (545): Lamictal (lamotrigine) Chewable Dispersible Tablet, GlaxoWellcome

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Lamictal (lamotrigine) Chewable Dispersible Tablet

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoWellcome
Approval Status: Approved June 1999
Treatment for: Neurology

General Information

The approval of these efficacy supplements provide for the use of Lamictal as conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing antiepileptic drug.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]